Market Cap
Company ProfileBiohaven Pharmaceutical Holding Company Ltd. Market Cap History
Market Cap: $1.68 Billion
USD as of Jul 1, 2023
Company ProfileBiohaven Pharmaceutical Holding Company Ltd. Market Capitalization Over Time
Evolution of Biohaven Pharmaceutical Holding Company Ltd. market cap history
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $209.25 B |
| Vertex Pharmaceuticals | $121.09 B |
| Regeneron Pharmaceuticals | $78.52 B |
| argenx | $52.93 B |
| Beigene Ltd. | $51.33 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
| Lilly | $1.024 T |
| Johnson & Johnson | $617.78 B |
| AbbVie | $443.36 B |
| Roche | $418.93 B |
| UnitedHealth Group | $376.34 B |
Yearly Market Cap Evolution
| Date | Market Cap | YoY Change |
|---|---|---|
| Jan. 1, 2023 | $1.27 B | -85.93% |
| Jan. 1, 2022 | $9.06 B | 55.91% |
| Jan. 1, 2021 | $5.81 B | 75.75% |
| Jan. 1, 2020 | $3.31 B | 27.30% |
| Jan. 1, 2019 | $2.60 B | 10.21% |
| Jan. 1, 2018 | $2.36 B |
Market capitalization is calculated from the opening stock price at the beginning of each year.
What is Market Capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.